Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 249

1.

HMG-CoA reductase inhibitors and myotoxicity.

Ucar M, Mjörndal T, Dahlqvist R.

Drug Saf. 2000 Jun;22(6):441-57. Review.

PMID:
10877038
[PubMed - indexed for MEDLINE]
2.

Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?

Evans M, Rees A.

Drug Saf. 2002;25(9):649-63. Review.

PMID:
12137559
[PubMed - indexed for MEDLINE]
3.

Comparative tolerability of the HMG-CoA reductase inhibitors.

Farmer JA, Torre-Amione G.

Drug Saf. 2000 Sep;23(3):197-213. Review.

PMID:
11005703
[PubMed - indexed for MEDLINE]
4.

Rhabdomyolysis and statin therapy: relevance to the elderly.

Sica DA, Gehr TW.

Am J Geriatr Cardiol. 2002 Jan-Feb;11(1):48-55. Review.

PMID:
11773716
[PubMed - indexed for MEDLINE]
5.

Genetic polymorphisms in cytochrome P450 enzymes: effect on efficacy and tolerability of HMG-CoA reductase inhibitors.

Vermes A, Vermes I.

Am J Cardiovasc Drugs. 2004;4(4):247-55. Review.

PMID:
15285699
[PubMed - indexed for MEDLINE]
6.

Statins and myotoxicity: a therapeutic limitation.

Tiwari A, Bansal V, Chugh A, Mookhtiar K.

Expert Opin Drug Saf. 2006 Sep;5(5):651-66. Review.

PMID:
16907655
[PubMed - indexed for MEDLINE]
7.

HMG-CoA-reductase inhibitors and neuropathy: reports to the Netherlands Pharmacovigilance Centre.

de Langen JJ, van Puijenbroek EP.

Neth J Med. 2006 Oct;64(9):334-8.

PMID:
17057271
[PubMed - indexed for MEDLINE]
Free Article
8.

Safety profiles for the HMG-CoA reductase inhibitors: treatment and trust.

Davidson MH.

Drugs. 2001;61(2):197-206. Review.

PMID:
11270938
[PubMed - indexed for MEDLINE]
9.

[Safety profile of statins].

Prieto JC.

Rev Med Chil. 2001 Nov;129(11):1237-40. Spanish.

PMID:
11836874
[PubMed - indexed for MEDLINE]
10.

Statin-induced myopathy: the two faces of Janus.

Arora R, Liebo M, Maldonado F.

J Cardiovasc Pharmacol Ther. 2006 Jun;11(2):105-12. Review.

PMID:
16891287
[PubMed - indexed for MEDLINE]
11.

HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles.

Beaird SL.

J Am Pharm Assoc (Wash). 2000 Sep-Oct;40(5):637-44. Review.

PMID:
11029845
[PubMed - indexed for MEDLINE]
12.

Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors.

Molden E, Skovlund E, Braathen P.

Drug Saf. 2008;31(7):587-96.

PMID:
18558792
[PubMed - indexed for MEDLINE]
13.

Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.

Rosenson RS.

Am J Cardiovasc Drugs. 2001;1(6):411-20. Review.

PMID:
14728000
[PubMed - indexed for MEDLINE]
14.

Pharmacological interactions of statins.

Paoletti R, Corsini A, Bellosta S.

Atheroscler Suppl. 2002 May;3(1):35-40. Review.

PMID:
12044584
[PubMed - indexed for MEDLINE]
15.

Protective effects of a squalene synthase inhibitor, lapaquistat acetate (TAK-475), on statin-induced myotoxicity in guinea pigs.

Nishimoto T, Ishikawa E, Anayama H, Hamajyo H, Nagai H, Hirakata M, Tozawa R.

Toxicol Appl Pharmacol. 2007 Aug 15;223(1):39-45. Epub 2007 May 24.

PMID:
17599378
[PubMed - indexed for MEDLINE]
16.

Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.

Martin JE, Cavanaugh TM, Trumbull L, Bass M, Weber F Jr, Aranda-Michel J, Hanaway M, Rudich S.

Clin Transplant. 2008 Jan-Feb;22(1):113-9. doi: 10.1111/j.1399-0012.2007.00780.x.

PMID:
18217912
[PubMed - indexed for MEDLINE]
17.

Statin safety and drug interactions: clinical implications.

Bottorff MB.

Am J Cardiol. 2006 Apr 17;97(8A):27C-31C. Epub 2006 Jan 25. Review.

PMID:
16581325
[PubMed - indexed for MEDLINE]
18.

Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor.

Kajinami K, Takekoshi N, Saito Y.

Cardiovasc Drug Rev. 2003 Fall;21(3):199-215. Review.

PMID:
12931254
[PubMed - indexed for MEDLINE]
19.

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Tobert JA.

Nat Rev Drug Discov. 2003 Jul;2(7):517-26. Review.

PMID:
12815379
[PubMed - indexed for MEDLINE]
20.

Statin safety: an assessment using an administrative claims database.

Cziraky MJ, Willey VJ, McKenney JM, Kamat SA, Fisher MD, Guyton JR, Jacobson TA, Davidson MH.

Am J Cardiol. 2006 Apr 17;97(8A):61C-68C. Epub 2006 Jan 30.

PMID:
16581331
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk